|
HADHA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20910000012131E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.751700E-04 |
| Normal-vs-Stage2 |
6.640100E-03 |
| Normal-vs-Stage3 |
9.34190003132329E-09 |
| Normal-vs-Stage4 |
4.28340000024896E-07 |
| Stage1-vs-Stage2 |
5.885000E-01 |
| Stage1-vs-Stage3 |
3.117400E-03 |
| Stage1-vs-Stage4 |
1.316120E-02 |
| Stage2-vs-Stage3 |
1.220030E-01 |
| Stage2-vs-Stage4 |
1.730440E-01 |
| Stage3-vs-Stage4 |
9.442400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.35219999997905E-07 |
| Normal-vs-AfricanAmerican |
7.05629999986357E-08 |
| Normal-vs-Asian |
1.923500E-02 |
| Caucasian-vs-AfricanAmerican |
1.707610E-02 |
| Caucasian-vs-Asian |
7.137200E-01 |
| AfricanAmerican-vs-Asian |
5.236800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20059526157002E-11 |
| Normal-vs-Female |
1.079200E-01 |
| Male-vs-Female |
1.21129999997027E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.96350000042567E-07 |
| Normal-vs-Age(41-60Yrs) |
2.83660000044428E-07 |
| Normal-vs-Age(61-80Yrs) |
4.44579999999695E-05 |
| Normal-vs-Age(81-100Yrs) |
4.501700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.039800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.720000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.724410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.649400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.751200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.293000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.106000E-02 |
| Normal-vs-Grade 2 |
9.623700E-04 |
| Normal-vs-Grade 3 |
1.34340000002009E-06 |
| Normal-vs-Grade 4 |
1.30789823415967E-11 |
| Grade 1-vs-Grade 2 |
6.853800E-01 |
| Grade 1-vs-Grade 3 |
5.428000E-01 |
| Grade 1-vs-Grade 4 |
3.812300E-02 |
| Grade 2-vs-Grade 3 |
9.923700E-02 |
| Grade 2-vs-Grade 4 |
3.202200000052E-06 |
| Grade 3-vs-Grade 4 |
1.578740E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.195200E-01 |
| Normal-vs-ccB subtype |
3.93018950717305E-14 |
| ccA subtype-vs-ccB subtype |
3.77475828372553E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.793150E-04 |
| Normal-vs-N1 |
4.614000E-02 |
| N0-vs-N1 |
3.223200E-01 |
|
|
